| Not Yet Recruiting | Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. Androgenetic Alopecia, Androgenetic Alopecia (AGA) | Phase 3 | 2027-01-31 |
| Not Yet Recruiting | Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair L Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia | Phase 3 | 2027-01-01 |
| Not Yet Recruiting | Efficacy and Safety of Two Fixed-dose Combinations in Men with Lower Urinary Tract Symptoms Associated with Be Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms | Phase 3 | 2026-11-30 |
| Not Yet Recruiting | Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension Essential Arterial Hypertension | Phase 3 | 2026-11-30 |
| Withdrawn | iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Met Diabetes Mellitus, Type 2 | Phase 3 | 2026-11-30 |
| Not Yet Recruiting | Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in P Moderate Asthma | Phase 3 | 2026-10-01 |
| Not Yet Recruiting | Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLA Chronic Obstructive Pulmonary Disease | Phase 3 | 2026-09-01 |
| Withdrawn | Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diab Type 2 Diabetes Mellitus (T2DM) | Phase 3 | 2026-09-01 |
| Withdrawn | Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil Moderate Asthma | Phase 3 | 2026-06-01 |
| Withdrawn | Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil Third Molar Extraction | Phase 3 | 2026-05-30 |
| Withdrawn | Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neu Painful Diabetic Peripheral Neuropathy (PDPN) | Phase 3 | 2026-04-01 |
| Withdrawn | A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight, Obesity | Phase 3 | 2026-04-01 |
| Withdrawn | Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazi Allergic Rhinitis | Phase 3 | 2026-03-01 |
| Not Yet Recruiting | Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris Acne Vulgaris, Acne Vulgaris on the Face | Phase 3 | 2026-03-01 |
| Not Yet Recruiting | Evaluation of the EF192B Protection Versus No Treatment Skin Lesions, Skin Care | N/A | 2025-08-31 |
| Completed | Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment Cold, Flu Symptom | Phase 3 | 2025-03-26 |
| Completed | Evaluation of the Protection of a Liquid Bandage Skin Care | N/A | 2025-02-18 |
| Completed | Evaluation of Skin Irritancy and Sensitization of a Liquid Bandage Skin Care | N/A | 2025-01-31 |
| Completed | Assessment of EF192A Potential Sensitization and Accumulated and Primary Irritability in Controlled/Maximized Skin Lesion, Skin Lesions, Skin Care | N/A | 2025-01-20 |
| Withdrawn | Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbiditi Overweight, Obesity | — | 2024-12-01 |
| Completed | Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis i Allergic Rhinitis | Phase 3 | 2024-07-08 |
| Completed | Fixed-dose Combination of Oxycodone [OXIcodona] + IbuproFEN in Pain Relief After Third Molar Extraction Pain | Phase 3 | 2024-03-27 |
| Completed | Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Mo Pain | Phase 3 | 2023-11-08 |
| Completed | A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Asthma Copd | Phase 3 | 2023-04-19 |
| Completed | Treatment of Androgenetic Alopecia in Men for 24 Weeks Alopecia | Phase 3 | 2023-03-02 |
| Completed | Efficacy and Safety of Rizatriptan-Naproxen (10/550 Mg) in the Acute Treatment of Migraine Migraine | Phase 3 | 2022-12-30 |
| Terminated | Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Bre Breast Cancer | Phase 3 | 2020-10-30 |
| Completed | Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer Advanced Prostate Cancer | Phase 3 | 2020-09-30 |
| Withdrawn | Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis Rhinitis, Allergic, Perennial | Phase 3 | 2019-10-08 |
| Completed | The Effect of a Multivitamin in the Treatment of Memory Loss in Postmenopausal Women Memory Disorders, Postmenopausal Symptoms | N/A | 2019-01-23 |
| Withdrawn | A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical St Knee Osteoarthritis | Phase 3 | 2019-01-01 |
| Withdrawn | Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast C Breast Cancer | Phase 3 | 2018-01-01 |
| Completed | Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2) Diabetes Mellitus, Type 2 | Phase 2 | 2017-08-08 |
| Completed | Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL) Osteoarthritis of Knee | Phase 3 | 2016-12-05 |
| Withdrawn | Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis Rhinitis, Allergic, Perennial | Phase 3 | 2016-06-01 |
| Completed | Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations Neutropenia, Healthy | Phase 1 | 2015-11-01 |
| Withdrawn | Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab Carcinoma, Head and Neck Cancer | Phase 3 | 2013-11-01 |
| Withdrawn | Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at Gastroesophageal Reflux Disease | Phase 3 | 2013-08-01 |
| Withdrawn | Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol Metrorrhagia | Phase 3 | 2013-07-01 |
| Withdrawn | Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Acute Lumbago | Phase 3 | 2013-05-01 |
| Withdrawn | Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI) Cystitis | Phase 3 | 2012-10-01 |
| Terminated | Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation Non ST Segment Elevation Myocardial Infarction, Unstable Angina | Phase 3 | 2012-07-01 |
| Completed | A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Momet Mild to Moderate Persistent Allergic Rhinitis | Phase 3 | 2012-06-01 |
| Withdrawn | Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in t Antibiotics | Phase 3 | 2012-02-01 |
| Completed | A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients Asthma | Phase 3 | 2012-01-01 |
| Terminated | A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery Hip Fracture Surgery | Phase 3 | 2011-10-01 |
| Completed | Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension Arterial Hypertension | Phase 3 | 2011-08-01 |
| Completed | A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with A Asthma | Phase 3 | 2011-08-01 |
| Completed | A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI) Hypolactasia | Phase 3 | 2011-07-01 |
| Completed | A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia Lactose Intolerance | Phase 3 | 2011-06-01 |
| Completed | A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma Asthma | Phase 3 | 2011-04-01 |
| Completed | A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment o INSOMNIA | Phase 3 | 2011-03-01 |
| Completed | Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma Diffuse Intrinsic Brainstem Gliomas | Phase 2 | 2011-03-01 |
| Completed | A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer Neutropenia in Breast Cancer | Phase 3 | 2011-03-01 |
| Completed | Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Lumbar Sciatic Pain | Phase 3 | 2011-02-01 |
| Withdrawn | Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Carcinoma, Adenocarcinoma, Uterine Cervix Adenosquamous Carcinoma | Phase 2 | 2011-01-01 |
| Terminated | Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema Congestive Heart Failure | Phase 3 | 2011-01-01 |
| Completed | Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Osteoarthritis of the Knee | Phase 3 | 2010-08-01 |
| Completed | Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Allergic Rhinitis | Phase 3 | 2010-02-01 |
| Completed | A Comparative Study Between Foraseq and Formoterol/Budesonide Inhalation Capsules in Patients with Asthma ASTHMA | Phase 3 | 2010-02-01 |
| Completed | A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer Esophageal Cancer, Adenocarcinoma | Phase 2 / Phase 3 | 2009-01-01 |
| Completed | UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit. Hemodialysis Complication | Phase 3 | 2007-08-01 |
| Withdrawn | Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment o Gastroesophageal Reflux Disease | Phase 3 | — |